The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease. Kim Smith-Whitley, MD, Director of the Comprehensive Sickle Cell Center and the Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED), says these medications will augment the cutting-edge treatments CHOP offers to better manage this debilitating disease, as discussed in this Philadelphia Inquirer article.
Featured in this article
Specialties & Programs
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease. Kim Smith-Whitley, MD, Director of the Comprehensive Sickle Cell Center and the Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED), says these medications will augment the cutting-edge treatments CHOP offers to better manage this debilitating disease, as discussed in this Philadelphia Inquirer article.
Contact us
Sickle Cell Center